Physician profile
Matthew B Jaffe
NPI 1831192848
$1,026.44
in general payments reported to CMS, 2019-2025
15 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2021: $43.20 · 2022: $73.44 · 2023: $110 · 2024: $131 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $374.09 | 2019-2025 | Na, Coblation, Bone Anchors With Arthroscopic Delivery System |
| Ferring Pharmaceuticals INC. | $140.72 | 2019-2024 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $111.92 | 2019 | |
| Ermi LLC | $94.88 | 2023-2025 | |
| Moximed, INC | $52.55 | 2025 | Misha Knee System, Small, Left |
| Becton, Dickinson and Company | $49.38 | 2024 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $42.65 | 2022-2025 | Healix Knotless Peek |
| Bioventus LLC | $30.81 | 2019 | |
| Zyla Life Sciences, INC. | $28.67 | 2019 | |
| Boston Scientific Corporation | $28.49 | 2025 | Wavewriter Alpha Prime 16 |
| Inspire Medical Systems, INC. | $18.54 | 2025 | Inspire |
| Abbvie INC. | $18.27 | 2025 | |
| Fidia Pharma USA INC. | $14.20 | 2019 | |
| Amniox Medical, INC. | $11.42 | 2019 | |
| Orthofix Medical, INC. | $9.85 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.